What's new in atopic eczema? An analysis of systematic reviews published in 2018. Part 1: prevention and topical therapies. (27th August 2020)
- Record Type:
- Journal Article
- Title:
- What's new in atopic eczema? An analysis of systematic reviews published in 2018. Part 1: prevention and topical therapies. (27th August 2020)
- Main Title:
- What's new in atopic eczema? An analysis of systematic reviews published in 2018. Part 1: prevention and topical therapies
- Authors:
- Tasker, F.
Brown, A.
Grindlay, D. J. C.
Rogers, N. K.
Harman, K. E. - Abstract:
- Summary: This review is part of a series of annual updates that summarize the evidence base for atopic eczema (AE). The aim is to provide a succinct guide for clinicians on the key findings from 14 systematic reviews on the prevention and topical treatment of AE published or indexed in 2018. Various supplements, including long‐chain polyunsaturated fatty acids, vitamin D and the probiotic Lactobacillus rhamnosus GG, given prenatally and postnatally, have not been shown to prevent AE in infants, although mixed strains of probiotics may decrease the risk of AE if given to the mother during pregnancy and to the infant for the first 6 months of life. In the postnatal period, there is no evidence that hydrolysed formula, compared with cow's milk formula (CMF), reduces the risk of AE in partially breastfed infants. However, weak evidence suggests that a specific partially hydrolysed whey formula decreases the risk of AE compared with CMF. No specific skin practices can be recommended to reduce the eczema risk in healthy term babies. There is weak evidence of a low risk of reversible hypothalamic–pituitary–adrenal axis suppression following 2–4 weeks of treatment with low‐potency topical steroids, and conflicting evidence as to whether bleach bathing affects skin flora or AE severity. A single study demonstrated that the topical Janus kinase inhibitor tofacitinib at 2% significantly reduces the Eczema Area and Severity Index compared with vehicle. Topical naltrexone cream 1%Summary: This review is part of a series of annual updates that summarize the evidence base for atopic eczema (AE). The aim is to provide a succinct guide for clinicians on the key findings from 14 systematic reviews on the prevention and topical treatment of AE published or indexed in 2018. Various supplements, including long‐chain polyunsaturated fatty acids, vitamin D and the probiotic Lactobacillus rhamnosus GG, given prenatally and postnatally, have not been shown to prevent AE in infants, although mixed strains of probiotics may decrease the risk of AE if given to the mother during pregnancy and to the infant for the first 6 months of life. In the postnatal period, there is no evidence that hydrolysed formula, compared with cow's milk formula (CMF), reduces the risk of AE in partially breastfed infants. However, weak evidence suggests that a specific partially hydrolysed whey formula decreases the risk of AE compared with CMF. No specific skin practices can be recommended to reduce the eczema risk in healthy term babies. There is weak evidence of a low risk of reversible hypothalamic–pituitary–adrenal axis suppression following 2–4 weeks of treatment with low‐potency topical steroids, and conflicting evidence as to whether bleach bathing affects skin flora or AE severity. A single study demonstrated that the topical Janus kinase inhibitor tofacitinib at 2% significantly reduces the Eczema Area and Severity Index compared with vehicle. Topical naltrexone cream 1% improves pruritus (measured using a visual analogue scale) by 30% more than placebo. There is weak evidence that topical alternative therapies, including antioxidants, micronutrients and some herbal medicines, may improve AE. Abstract : Click here for the corresponding questions to this CME article. … (more)
- Is Part Of:
- Clinical and experimental dermatology. Volume 45:Number 8(2020)
- Journal:
- Clinical and experimental dermatology
- Issue:
- Volume 45:Number 8(2020)
- Issue Display:
- Volume 45, Issue 8 (2020)
- Year:
- 2020
- Volume:
- 45
- Issue:
- 8
- Issue Sort Value:
- 2020-0045-0008-0000
- Page Start:
- 974
- Page End:
- 979
- Publication Date:
- 2020-08-27
- Subjects:
- Skin -- Diseases -- Periodicals
616.5 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2230 ↗
https://academic.oup.com/ced/issue ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/ced.14303 ↗
- Languages:
- English
- ISSNs:
- 0307-6938
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.250000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23815.xml